Medindia

X

Graymark Healthcare Partners With North Oak Medical Park of Kansas City, Missouri to Offer Comprehensive Sleep Care

Thursday, June 2, 2011 General News J E 4
Advertisement

OKLAHOMA CITY, June 2, 2011 /PRNewswire/ -- Graymark Healthcare, Inc. (NASDAQ: GRMH), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), has partnered with North Oak Medical Park of Kansas City to offer comprehensive sleep medicine services to the county's residents.

Offering the most comprehensive sleep care in the region, the new custom built sleep facility at North Oak Medical Park will be able to accommodate day and evening sleep testing services seven days a week. The facility provides a comprehensive care model of sleep medicine services through partnerships with the Midwest Sleep Specialists, somniTech sleep testing, and somniCare CPAP/BiPAP equipment. This enables patients to get their sleep disorders diagnosed and treated all in one convenient location.

North Oak Medical Park increases the total number of agreements for Graymark to eight so far in 2011. The company appears well on track to exceed the 11 partnerships it established in 2010, including six in the fourth quarter. The growing number is the result of Graymark's successful nationwide campaign to deliver sleep medicine care in familiar, local surroundings, while ensuring the care meets national standards. In particular, the new relationship with North Oak Medical Park also demonstrates Graymark's commitment to deliver sleep medicine to rural communities that may not otherwise have practical access to comprehensive sleep care.

These sleep medicine programs augment the company-owned, freestanding facilities, and represent Graymark's go-to-market strategy due to the relatively low start-up cost and more rapid deployment, as well as lower ongoing administrative time and expense. Graymark's OSA patients also benefit from the full and immediate resources of a well-established, professionally operated medical facility.

"Our partnership with somniTech sleep testing services and Graymark Healthcare to provide a seamless continuity of care between our board-certified sleep physicians and their testing and treatment capabilities is an exciting addition to the North Oak Medical Park multi-specialty building," said Dr. Steven Hull, president of Midwest Sleep Specialists. "We have been warmly received by the physicians in this region as a needed specialty area."

Graymark now operates a total of 99 sleep laboratories nationwide, comprised of 24 standalone or IDTF facilities in large communities and 75 hospital or rural outreach locations. While the care environments may vary based on community need, Graymark ensures that the quality and comprehensiveness of the services provided remain consistently at the highest standard. To find out more or to locate a sleep center near you, visit www.graymarkhealthcare.com.

About North Oak Medical Park

North Oak Medical Park consists of a 175,000 square foot multi-phase, three building medical office park located on 12.33 acres in Kansas City, Missouri.

About Graymark Healthcare

Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (NASDAQ:GRMH) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 99 sleep laboratories throughout the United States, including standalone or IDTF facilities, rural outreach sites and hospital or provider agreements. For more information, visit www.graymarkhealthcare.com.

Important Cautions Regarding Forward-Looking Statements

This press release may contain forward-looking statements that are based on the company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the company, including, without limitation, the current economic climate and other risks and uncertainties, including those enumerated and described in the company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at www.sec.gov. Unless otherwise required by law, the company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Graymark Healthcare, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ThermoGenesis Announces 510(k) Approval for Use of...
S
Syndax Pharmaceuticals Announces Issuance of US Pa...